Sands Capital Alternatives, LLC
Position in CADL — Candel Therapeutics, Inc.
CIK 1846444
ARLINGTON, VA
Position in CADL
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,988,601
-$304,378 QoQ
Shares Held
405,837
0.0% QoQ
Ownership
0.554%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sands Capital Alternatives, LLC holds $109,568,571 across 7 Biotechnology names. CADL ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SGP |
SpyGlass Pharma, Inc.
|
2,500,012 | $64,775,310 | |
| 2 | IKT |
Inhibikase Therapeutics, Inc.
|
13,018,965 | $21,871,861 | |
| 3 | ABOS |
Acumen Pharmaceuticals, Inc.
|
3,720,105 | $8,779,447 | |
| 4 | TARS |
Tarsus Pharmaceuticals, Inc.
|
85,000 | $5,962,750 | |
| 5 | TSHA |
Taysha Gene Therapies, Inc.
|
724,873 | $3,240,182 | |
| 6 | ACRV |
Acrivon Therapeutics, Inc.
|
2,122,605 | $2,950,420 | |
| 7 | CADL |
Candel Therapeutics, Inc.
This page
|
405,837 | $1,988,601 |
All Filings in CADL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,988,601 | 405,837 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,292,979 | 405,837 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,069,768 | 405,837 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,053,535 | 405,837 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,292,979 | 405,837 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,522,665 | 405,837 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,812,450 | 405,837 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,516,189 | 405,837 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,282,544 | 811,737 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,193,253 | 811,737 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $746,798 | 811,737 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,022,788 | 811,737 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,095,844 | 811,737 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,453,009 | 811,737 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,548,854 | 811,737 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,630,027 | 811,737 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,131,741 | 811,737 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,347,783 | 811,737 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $8,799,229 | 811,737 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||